Press Releases

  1. Press Releases

Press Releases

Press Releases

December 6, 2019
CAMBRIDGE, Mass. and ROSTOCK, Germany, Dec. 06, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG) today announced the expansion of its executive leadership team with the appointment of Philip Lambert, PhD in Cambridge, MA as Chief Scientific Officer .
November 7, 2019
CAMBRIDGE, Mass. and ROSTOCK, Germany, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Centogene B.V. (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical
November 7, 2019
Cambridge, MA, USA & Rostock, Deutschland, 6. November 2019 – Centogene B.V. („CENTOGENE“ oder das „Unternehmen“), ein auf seltene Erkrankungen spezialisiertes Unternehmen, welches klinische und genetische Daten zur Beantwortung medizinischer Fragen für Patienten, Ärzte und pharmazeutische
October 28, 2019
CAMBRIDGE, Mass. and ROSTOCK, Germany, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Centogene B.V. (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical
June 28, 2019
Driving Accelerated Diagnosis and Treatment Development CENTOGENE today revealed the growth in its knowledge-base of rare hereditary diseases. In today’s update to CentoMD®  ̶  the Company’s data repository of epidemiologic, phenotypic and clinical data, since December 2018 the number of analyzed